中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2014年
11期
2498-2501
,共4页
缺血前预处理%缺血后再灌注损伤%阿托伐他汀%心肌保护
缺血前預處理%缺血後再灌註損傷%阿託伐他汀%心肌保護
결혈전예처리%결혈후재관주손상%아탁벌타정%심기보호
Ischemic preconditioning%Ischemia reperfusion injury%Atorvastatin%Myocardial protection
目的 探讨缺血前预处理对心脏缺血后再灌注损伤的影响与机制.方法 健康清洁级雄性SD大鼠66只,均建立缺血再灌注(I/R)型,然后分为3个实验组,每组22只大鼠,具体为(1)对照(control)组:心脏持续缓冲液灌注;(2) I/R组:心脏接受30 min全心缺血后行120 min再灌注;(3)阿托伐他汀处理(Ator)组:全心缺血前给予Ator 1 μmol/L灌流30 min后行I/R处理.观察与测定3组的心肌超微结构、心梗面积、血流动力学、血清乳酸脱氢酶含量、三磷酸腺苷(ATP)与烟酰胺腺嘌呤二核苷酸(NAD+)水平.结果 I/R组与Ator组结扎前降支后心电图ST段弓背向上抬高,与T波融合;control组手术前后心电图无明显变化;与I/R组比较,Ator组的心肌梗死面积显著减少(P<0.05).显微结构显示3组中心肌细胞水肿、肌原纤维排列、线粒体结构与糖原颗粒都有明显不同.L/R后,I/R组与Ator组左室收缩压(LVSP)、左室压力下降的峰速度(dp/dtmin)和心率(HR)值明显降低,而左室舒张末期压(LVEDP)明显升高(P<0.05);Ator组中上述值LVSP与dp/dtmin值明显高于I/R组,而LVEDP与HR值明显低于I/R组(P<0.05).control组的乳酸脱氢酶(LDH)水平为(164.32±20.84) U/L,I/R组为(3589.63±133.25) U/L,Ator组为(1703.25±155.80) U/L,I/R组较control组LDH水平显著增加(P<0.05);而与I/R组比较,Ator组的LDH活性显著下降(P<0.05).与control组比较,I/R组内心肌ATP与NAD+含量明显降低(P<0.05);Ator组较I/R组心肌内ATP与NAD+含量显著升高(P<0.05).结论 阿托伐他汀预处理,在I/R损伤中能有效发挥保护心肌作用,其机制是通过线粒体ATP敏感性钾通道活化与降低心肌中LDH释放介导的.
目的 探討缺血前預處理對心髒缺血後再灌註損傷的影響與機製.方法 健康清潔級雄性SD大鼠66隻,均建立缺血再灌註(I/R)型,然後分為3箇實驗組,每組22隻大鼠,具體為(1)對照(control)組:心髒持續緩遲液灌註;(2) I/R組:心髒接受30 min全心缺血後行120 min再灌註;(3)阿託伐他汀處理(Ator)組:全心缺血前給予Ator 1 μmol/L灌流30 min後行I/R處理.觀察與測定3組的心肌超微結構、心梗麵積、血流動力學、血清乳痠脫氫酶含量、三燐痠腺苷(ATP)與煙酰胺腺嘌呤二覈苷痠(NAD+)水平.結果 I/R組與Ator組結扎前降支後心電圖ST段弓揹嚮上抬高,與T波融閤;control組手術前後心電圖無明顯變化;與I/R組比較,Ator組的心肌梗死麵積顯著減少(P<0.05).顯微結構顯示3組中心肌細胞水腫、肌原纖維排列、線粒體結構與糖原顆粒都有明顯不同.L/R後,I/R組與Ator組左室收縮壓(LVSP)、左室壓力下降的峰速度(dp/dtmin)和心率(HR)值明顯降低,而左室舒張末期壓(LVEDP)明顯升高(P<0.05);Ator組中上述值LVSP與dp/dtmin值明顯高于I/R組,而LVEDP與HR值明顯低于I/R組(P<0.05).control組的乳痠脫氫酶(LDH)水平為(164.32±20.84) U/L,I/R組為(3589.63±133.25) U/L,Ator組為(1703.25±155.80) U/L,I/R組較control組LDH水平顯著增加(P<0.05);而與I/R組比較,Ator組的LDH活性顯著下降(P<0.05).與control組比較,I/R組內心肌ATP與NAD+含量明顯降低(P<0.05);Ator組較I/R組心肌內ATP與NAD+含量顯著升高(P<0.05).結論 阿託伐他汀預處理,在I/R損傷中能有效髮揮保護心肌作用,其機製是通過線粒體ATP敏感性鉀通道活化與降低心肌中LDH釋放介導的.
목적 탐토결혈전예처리대심장결혈후재관주손상적영향여궤제.방법 건강청길급웅성SD대서66지,균건립결혈재관주(I/R)형,연후분위3개실험조,매조22지대서,구체위(1)대조(control)조:심장지속완충액관주;(2) I/R조:심장접수30 min전심결혈후행120 min재관주;(3)아탁벌타정처리(Ator)조:전심결혈전급여Ator 1 μmol/L관류30 min후행I/R처리.관찰여측정3조적심기초미결구、심경면적、혈류동역학、혈청유산탈경매함량、삼린산선감(ATP)여연선알선표령이핵감산(NAD+)수평.결과 I/R조여Ator조결찰전강지후심전도ST단궁배향상태고,여T파융합;control조수술전후심전도무명현변화;여I/R조비교,Ator조적심기경사면적현저감소(P<0.05).현미결구현시3조중심기세포수종、기원섬유배렬、선립체결구여당원과립도유명현불동.L/R후,I/R조여Ator조좌실수축압(LVSP)、좌실압력하강적봉속도(dp/dtmin)화심솔(HR)치명현강저,이좌실서장말기압(LVEDP)명현승고(P<0.05);Ator조중상술치LVSP여dp/dtmin치명현고우I/R조,이LVEDP여HR치명현저우I/R조(P<0.05).control조적유산탈경매(LDH)수평위(164.32±20.84) U/L,I/R조위(3589.63±133.25) U/L,Ator조위(1703.25±155.80) U/L,I/R조교control조LDH수평현저증가(P<0.05);이여I/R조비교,Ator조적LDH활성현저하강(P<0.05).여control조비교,I/R조내심기ATP여NAD+함량명현강저(P<0.05);Ator조교I/R조심기내ATP여NAD+함량현저승고(P<0.05).결론 아탁벌타정예처리,재I/R손상중능유효발휘보호심기작용,기궤제시통과선립체ATP민감성갑통도활화여강저심기중LDH석방개도적.
Objective To investigate the effects of pretreatment with atorvastatin (Ator) on the heart ischemia-reperfusion injury (IRI) and the possible mechanism.Methods After establishment of IRI models,66 healthy male SD rats were divided into three experimental groups (n =22 each).In control group,the rats were given cardiac perfusion continuous buffer.In IRI group,myocardia of rats accepted 30 min global ischemia and 120 min reperfusion.In Ator group,the rats were given 1 μmol/L Ator befor ischemia,and perfused for 30 min,followed by IRI.The myocardial ultrastructure,infarct size,hemodynamic,serum lactate dehydrogenase levels,adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide (NAD +) levels in three groups were observed.Results In IRI group and Ator group,arched upward ST segment elevation and T wave fusion after the anterior descending artery ligation were seen.The electrocardiogram (ECG) in the control group had no significant change after surgery.As compared with the IRI group,the myocardial infarction area in the Ator group was significantly decreased (P < 0.05).Microstructure showed that there was significant difference in the cardiomyocytes edema,myofibril,mitochondrial structure and glycogen granules among the three groups.After ischemia-reperfusion,the left ventricular systolic pressure (LVSP),peak velocity of left ventricular pressure drop (dp/dtmin) and heart rate (HR) values in the IRI group were decreased significantly,and the left ventricle end-diastolic pressure (LVEDP) values increased significantly (P < 0.05) as compared wiht the Ator group (P < 0.05).The lactate dehydrogenase (LDH) levels in the control group,IRI group and Ator group were (164.32 ± 20.84),(3589.63 ± 133.25) and (1703.25 ± 155.80) U/L respectively.The LDH levels in the IRI group were lower than in the control group,and those in IRI group were higher than in the Ator group (P < 0.05).The myocardial ATP and NAD + levels in the IRI group were decreased significantly as compared with the control group (P < 0.05),and increased as compared with the Ator group (P < 0.05).Conclusion Ischemic preconditioning with Ator for IRI can play an effective role in myocardial protection,which is achieved by activating the mitochondrial ATP-sensitive potassium channels and reducing lactic acid-mediated expression.